The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

Early detection and monitoring are key to the diagnosis and management of ocular diseases, including glaucoma, retinal and ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

Retinal Biologics Industry. The retinal biologics market experienced significant growth in 2021, with total revenue reaching ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

Avoid the most common diabetes complications with these helpful tips. Insulin is the main treatment for type 1 and 1.5 diabetes. It replaces the hormone your body isn’t able to produce.

While many types of dermatitis can be managed at home without medical treatment, you should consult a healthcare provider if you have any type of dermatitis with the following characteristics: ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

Global diabetic retinopathy market is anticipated to exhibit a CAGR of 6.43% during the forecast period 2024-2031 due to increasing prevalence of diabetes globally and rising demand for advanced ...